Sinovac Biotech, Ltd (SVA) Posts Q2 Loss of 2c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St futures up as oil slips; telecoms pressured by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- UBS flags level in gold prices where dip buyers will likely emerge
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- Investors need sustained Fed cuts to move cash off sidelines: BofA's Hartnett
Tweet
Share
E-mailGet Alerts SVA Hot Sheet
Join SI Premium – FREE
Sinovac Biotech, Ltd (NASDAQ: SVA) reported Q2 EPS of ($0.02), $0.08 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $9.37 million versus the consensus estimate of $8.3 million.
For earnings history and earnings-related data on Sinovac Biotech, Ltd (SVA) click here.
For earnings history and earnings-related data on Sinovac Biotech, Ltd (SVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- UnitedHealth Group (UNH) PT Lowered to $402 at TD Cowen
- Stifel updates midstream stock price targets ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
